SCHEMBL23633377

SCHEMBL23633377

CC(C)n1ncc2c(C(=O)Nc3ccc(F)cc3)cc(-c3cccs3)nc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 3/20 0.50
PSMD14 O00487 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
GGPS1 O95749 2/20 0.49
MAT2A P31153 3/20 0.48
OPRM1 P35372 1/20 0.47
OPRD1 P41143 1/20 0.47
KDM4E B2RXH2 6/20 0.47
ALDH1A1 P00352 6/20 0.47
MAPT P10636 6/20 0.47
HPGD P15428 5/20 0.47
GAA P10253 2/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
CNR1 P21554 2/20 0.45
RXFP1 Q9HBX9 2/20 0.44
FOXM1 Q08050 1/20 0.44
POLB P06746 1/20 0.43
EZH2 Q15910 1/20 0.43
GPR55 Q9Y2T6 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16783111 0.89 L3MBTL1 (0.49) TP53PSMD14L3MBTL1MAT2AOPRM1
SCHEMBL23633374 0.88 OPRM1 (0.48) TP53PSMD14L3MBTL1MAT2AOPRM1
SCHEMBL16783143 0.88 RXFP1 (0.47) PSMD14L3MBTL1MAT2AOPRM1OPRD1
SCHEMBL16783120 0.88 RXFP1 (0.54) TP53PSMD14L3MBTL1MAT2AOPRM1
SCHEMBL16783112 0.87 RXFP1 (0.48) TP53PSMD14L3MBTL1MAT2AOPRM1
SCHEMBL16783148 0.87 RXFP1 (0.46) TP53PSMD14L3MBTL1MAT2AOPRM1
SCHEMBL16783145 0.86 OPRM1 (0.51) PSMD14L3MBTL1MAT2AOPRM1OPRD1
SCHEMBL23633375 0.85 MAT2A (0.49) TP53PSMD14L3MBTL1MAT2AOPRM1
SCHEMBL20869961 0.84 TP53 (0.51) TP53KDM4EALDH1A1MAPTHPGD
SCHEMBL16783126 0.84 RXFP1 (0.55) TP53PSMD14L3MBTL1MAT2AOPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11180498-B2 Substituted pyrrolo[2,3-b]pyridines, pyrazolo[3,4-d]pyrimidines and [1,2,3]triazolo[4,5-b]pyridines as potent antivirals THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-11-23 US disclosed
US-11059817-B2 Potent antiviral pyrazolopyridine compounds THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11180498-B2 Substituted pyrrolo[2,3-b]pyridines, pyrazolo[3,4-d]pyrimidines and [1,2,3]triazolo[4,5-b]pyridines as potent antivirals PNPO, TYMS, TYMP TP53 2623/4885PSMD14 4306/4885L3MBTL1 2588/4885
US-11059817-B2 Potent antiviral pyrazolopyridine compounds MAVS, VRK1, VRK2 TP53 3148/4885PSMD14 3464/4885L3MBTL1 3199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.